| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 74 | 2025 | 1062 | 6.990 |
Why?
|
| Erythrocytes | 41 | 2025 | 672 | 5.750 |
Why?
|
| Proteome | 31 | 2024 | 443 | 4.720 |
Why?
|
| Blood Preservation | 23 | 2025 | 271 | 4.470 |
Why?
|
| Blood Proteins | 14 | 2020 | 242 | 3.910 |
Why?
|
| Extracellular Matrix | 27 | 2025 | 504 | 3.600 |
Why?
|
| Extracellular Matrix Proteins | 13 | 2024 | 144 | 3.480 |
Why?
|
| Shock, Hemorrhagic | 21 | 2023 | 165 | 3.160 |
Why?
|
| Wounds and Injuries | 20 | 2024 | 711 | 3.020 |
Why?
|
| Fibrinolysis | 14 | 2022 | 137 | 2.990 |
Why?
|
| Blood Coagulation Disorders | 12 | 2023 | 167 | 2.950 |
Why?
|
| Metabolomics | 30 | 2025 | 652 | 2.810 |
Why?
|
| Metabolome | 20 | 2022 | 338 | 2.690 |
Why?
|
| Lymph | 8 | 2018 | 32 | 2.660 |
Why?
|
| Mass Spectrometry | 35 | 2023 | 716 | 2.650 |
Why?
|
| Hemolysis | 15 | 2025 | 199 | 2.560 |
Why?
|
| Plasma | 13 | 2024 | 206 | 1.860 |
Why?
|
| Peptide Hydrolases | 3 | 2023 | 107 | 1.680 |
Why?
|
| Chromatography, Liquid | 16 | 2020 | 423 | 1.560 |
Why?
|
| Multiple Trauma | 4 | 2024 | 101 | 1.410 |
Why?
|
| Animals | 132 | 2025 | 35360 | 1.390 |
Why?
|
| Mesentery | 5 | 2014 | 47 | 1.370 |
Why?
|
| Erythrocyte Transfusion | 11 | 2025 | 181 | 1.370 |
Why?
|
| Tandem Mass Spectrometry | 15 | 2018 | 524 | 1.300 |
Why?
|
| Glycolysis | 9 | 2024 | 311 | 1.270 |
Why?
|
| Arginine | 7 | 2024 | 265 | 1.170 |
Why?
|
| Thrombelastography | 13 | 2024 | 150 | 1.110 |
Why?
|
| Hypoxia | 9 | 2024 | 1084 | 1.080 |
Why?
|
| Blood Platelets | 7 | 2022 | 380 | 1.060 |
Why?
|
| Isotope Labeling | 6 | 2018 | 74 | 1.040 |
Why?
|
| Tissue Plasminogen Activator | 10 | 2023 | 222 | 1.000 |
Why?
|
| Humans | 179 | 2025 | 129621 | 0.990 |
Why?
|
| Oxidative Stress | 18 | 2025 | 1269 | 0.970 |
Why?
|
| Fibrin | 4 | 2025 | 70 | 0.930 |
Why?
|
| Plateletpheresis | 2 | 2015 | 27 | 0.930 |
Why?
|
| Thrombosis | 7 | 2023 | 343 | 0.920 |
Why?
|
| Energy Metabolism | 11 | 2024 | 874 | 0.920 |
Why?
|
| Collagen | 8 | 2022 | 434 | 0.910 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2024 | 341 | 0.910 |
Why?
|
| Disease Models, Animal | 19 | 2025 | 4063 | 0.900 |
Why?
|
| Crotalus | 4 | 2025 | 26 | 0.860 |
Why?
|
| Crotalid Venoms | 4 | 2025 | 31 | 0.860 |
Why?
|
| Protein Domains | 4 | 2022 | 253 | 0.850 |
Why?
|
| Furin | 1 | 2022 | 13 | 0.820 |
Why?
|
| Hemorrhage | 9 | 2023 | 678 | 0.820 |
Why?
|
| Glycocalyx | 3 | 2022 | 21 | 0.820 |
Why?
|
| Mice | 56 | 2025 | 16937 | 0.810 |
Why?
|
| Fibrinogen | 7 | 2025 | 164 | 0.810 |
Why?
|
| Balloon Occlusion | 4 | 2024 | 34 | 0.810 |
Why?
|
| Lymph Nodes | 3 | 2018 | 472 | 0.810 |
Why?
|
| Vascular Remodeling | 1 | 2024 | 192 | 0.800 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2024 | 532 | 0.780 |
Why?
|
| Complement System Proteins | 3 | 2024 | 313 | 0.780 |
Why?
|
| Resuscitation | 12 | 2024 | 237 | 0.770 |
Why?
|
| Breast Neoplasms | 11 | 2021 | 2142 | 0.770 |
Why?
|
| Tissue Scaffolds | 4 | 2025 | 201 | 0.770 |
Why?
|
| Biomarkers | 22 | 2024 | 3973 | 0.750 |
Why?
|
| Male | 81 | 2025 | 63674 | 0.740 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 341 | 0.730 |
Why?
|
| Peptides | 7 | 2023 | 925 | 0.730 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 335 | 0.730 |
Why?
|
| Proteins | 6 | 2022 | 942 | 0.720 |
Why?
|
| Hemoglobins | 5 | 2023 | 339 | 0.710 |
Why?
|
| Saccharomyces cerevisiae Proteins | 9 | 2024 | 385 | 0.710 |
Why?
|
| Amino Acids | 7 | 2022 | 485 | 0.710 |
Why?
|
| Mammary Glands, Animal | 6 | 2021 | 124 | 0.710 |
Why?
|
| Oxidation-Reduction | 15 | 2022 | 1033 | 0.700 |
Why?
|
| Myocardium | 7 | 2024 | 980 | 0.690 |
Why?
|
| Sex Characteristics | 4 | 2022 | 737 | 0.690 |
Why?
|
| Blood Banks | 3 | 2021 | 40 | 0.690 |
Why?
|
| Blood Donors | 6 | 2025 | 96 | 0.690 |
Why?
|
| Female | 80 | 2025 | 68770 | 0.690 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2022 | 2406 | 0.680 |
Why?
|
| Pentose Phosphate Pathway | 5 | 2021 | 50 | 0.680 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2017 | 330 | 0.680 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 4 | 2022 | 84 | 0.680 |
Why?
|
| Endothelial Cells | 6 | 2023 | 749 | 0.660 |
Why?
|
| Peptide Mapping | 3 | 2019 | 63 | 0.660 |
Why?
|
| Chromatography, High Pressure Liquid | 12 | 2019 | 582 | 0.660 |
Why?
|
| Interleukin-6 | 2 | 2020 | 720 | 0.650 |
Why?
|
| Hypertension, Pulmonary | 4 | 2024 | 1894 | 0.640 |
Why?
|
| Factor XIIIa | 1 | 2019 | 5 | 0.640 |
Why?
|
| Rats | 28 | 2023 | 5499 | 0.630 |
Why?
|
| Sciuridae | 2 | 2019 | 146 | 0.620 |
Why?
|
| Actins | 3 | 2020 | 411 | 0.620 |
Why?
|
| Blood Coagulation | 7 | 2024 | 238 | 0.600 |
Why?
|
| Sodium Chloride | 3 | 2015 | 138 | 0.590 |
Why?
|
| Hydroxylamine | 1 | 2017 | 7 | 0.570 |
Why?
|
| Carbon | 2 | 2017 | 210 | 0.560 |
Why?
|
| Postpartum Period | 4 | 2020 | 332 | 0.550 |
Why?
|
| RNA-Binding Proteins | 4 | 2025 | 388 | 0.550 |
Why?
|
| Glucose | 5 | 2018 | 1003 | 0.550 |
Why?
|
| Extracellular Vesicles | 4 | 2024 | 130 | 0.550 |
Why?
|
| Neutrophils | 7 | 2022 | 1205 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 6 | 2021 | 882 | 0.540 |
Why?
|
| Hibernation | 2 | 2019 | 74 | 0.540 |
Why?
|
| High-Throughput Screening Assays | 5 | 2021 | 138 | 0.530 |
Why?
|
| Pandemics | 4 | 2023 | 1485 | 0.530 |
Why?
|
| Citric Acid | 1 | 2016 | 30 | 0.530 |
Why?
|
| Tumor Microenvironment | 9 | 2021 | 634 | 0.530 |
Why?
|
| Swine | 14 | 2024 | 760 | 0.530 |
Why?
|
| Adult | 47 | 2025 | 35572 | 0.510 |
Why?
|
| Brain Death | 1 | 2016 | 46 | 0.510 |
Why?
|
| Citrates | 2 | 2017 | 42 | 0.510 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.500 |
Why?
|
| Succinic Acid | 5 | 2020 | 39 | 0.500 |
Why?
|
| Lung | 9 | 2022 | 3931 | 0.500 |
Why?
|
| RNA Splicing | 4 | 2024 | 262 | 0.500 |
Why?
|
| Metabolic Flux Analysis | 1 | 2015 | 7 | 0.490 |
Why?
|
| Tissue Engineering | 3 | 2019 | 396 | 0.490 |
Why?
|
| Protein Processing, Post-Translational | 9 | 2019 | 455 | 0.490 |
Why?
|
| Hydroxylysine | 1 | 2015 | 4 | 0.490 |
Why?
|
| Altitude Sickness | 5 | 2017 | 140 | 0.480 |
Why?
|
| Protein C | 3 | 2024 | 47 | 0.480 |
Why?
|
| Phosphates | 2 | 2020 | 180 | 0.470 |
Why?
|
| Extinction, Biological | 1 | 2015 | 32 | 0.470 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 45 | 0.460 |
Why?
|
| Neoplasm Proteins | 4 | 2025 | 424 | 0.450 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 61 | 0.450 |
Why?
|
| Injury Severity Score | 5 | 2020 | 509 | 0.450 |
Why?
|
| Fibrosis | 5 | 2024 | 520 | 0.450 |
Why?
|
| Mammary Glands, Human | 3 | 2025 | 64 | 0.440 |
Why?
|
| Amino Acid Sequence | 10 | 2019 | 2058 | 0.430 |
Why?
|
| Reperfusion Injury | 5 | 2023 | 272 | 0.430 |
Why?
|
| Chondrogenesis | 3 | 2020 | 82 | 0.420 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 274 | 0.420 |
Why?
|
| Inflammation | 9 | 2024 | 2736 | 0.420 |
Why?
|
| Time Factors | 14 | 2018 | 6556 | 0.410 |
Why?
|
| Cells, Cultured | 16 | 2023 | 4083 | 0.410 |
Why?
|
| Hydrogels | 6 | 2023 | 638 | 0.410 |
Why?
|
| Cerebral Hemorrhage | 2 | 2024 | 107 | 0.410 |
Why?
|
| Middle Aged | 31 | 2025 | 31150 | 0.410 |
Why?
|
| Adenine | 1 | 2014 | 256 | 0.400 |
Why?
|
| Taste Buds | 1 | 2015 | 204 | 0.400 |
Why?
|
| Adenosine | 4 | 2018 | 227 | 0.400 |
Why?
|
| Membrane Proteins | 7 | 2023 | 1119 | 0.400 |
Why?
|
| Spliceosomes | 4 | 2019 | 46 | 0.400 |
Why?
|
| Hemostatics | 2 | 2023 | 49 | 0.400 |
Why?
|
| Glucosephosphate Dehydrogenase | 3 | 2025 | 56 | 0.390 |
Why?
|
| Stromal Cells | 3 | 2020 | 107 | 0.390 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 80 | 0.390 |
Why?
|
| Superoxides | 2 | 2022 | 201 | 0.390 |
Why?
|
| Fibrinolysin | 3 | 2022 | 18 | 0.390 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2021 | 270 | 0.380 |
Why?
|
| Ibuprofen | 1 | 2012 | 81 | 0.380 |
Why?
|
| Solutions | 3 | 2019 | 151 | 0.380 |
Why?
|
| Blast Injuries | 2 | 2022 | 45 | 0.380 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 2832 | 0.380 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 2 | 2024 | 13 | 0.370 |
Why?
|
| Ribonucleoprotein, U4-U6 Small Nuclear | 3 | 2017 | 11 | 0.370 |
Why?
|
| Gelsolin | 3 | 2020 | 9 | 0.360 |
Why?
|
| Cell Line, Tumor | 16 | 2023 | 3215 | 0.360 |
Why?
|
| Epithelial Cells | 6 | 2025 | 1065 | 0.360 |
Why?
|
| Liver | 6 | 2025 | 1839 | 0.360 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2022 | 160 | 0.360 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 30 | 0.360 |
Why?
|
| Mitochondria | 4 | 2024 | 877 | 0.360 |
Why?
|
| Lysine | 4 | 2023 | 286 | 0.360 |
Why?
|
| Streptococcus pneumoniae | 2 | 2025 | 159 | 0.350 |
Why?
|
| Gamma Rays | 2 | 2021 | 54 | 0.350 |
Why?
|
| GTP-Binding Proteins | 3 | 2025 | 157 | 0.340 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 833 | 0.340 |
Why?
|
| DNA-Binding Proteins | 5 | 2025 | 1443 | 0.340 |
Why?
|
| Erythrocyte Membrane | 3 | 2021 | 49 | 0.340 |
Why?
|
| Mice, Knockout | 10 | 2025 | 2871 | 0.340 |
Why?
|
| Glutamine | 4 | 2019 | 99 | 0.340 |
Why?
|
| Adaptation, Physiological | 4 | 2017 | 513 | 0.330 |
Why?
|
| Membrane Lipids | 3 | 2020 | 91 | 0.320 |
Why?
|
| Muscle, Skeletal | 8 | 2025 | 1614 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 5440 | 0.320 |
Why?
|
| Fibroblasts | 6 | 2021 | 948 | 0.320 |
Why?
|
| Bacterial Proteins | 6 | 2025 | 835 | 0.320 |
Why?
|
| Workflow | 2 | 2023 | 155 | 0.320 |
Why?
|
| Exercise Tolerance | 2 | 2025 | 273 | 0.320 |
Why?
|
| Histones | 6 | 2022 | 588 | 0.310 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2022 | 148 | 0.310 |
Why?
|
| Ultrasonics | 1 | 2009 | 49 | 0.310 |
Why?
|
| Cellular Reprogramming | 2 | 2021 | 95 | 0.300 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2019 | 82 | 0.300 |
Why?
|
| RNA Polymerase II | 3 | 2025 | 317 | 0.300 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2021 | 202 | 0.300 |
Why?
|
| Factor XIII | 2 | 2025 | 5 | 0.300 |
Why?
|
| Lactic Acid | 4 | 2018 | 303 | 0.300 |
Why?
|
| Tranexamic Acid | 3 | 2019 | 37 | 0.300 |
Why?
|
| Endovascular Procedures | 2 | 2023 | 301 | 0.300 |
Why?
|
| Models, Molecular | 9 | 2021 | 1492 | 0.290 |
Why?
|
| Peptide Fragments | 6 | 2022 | 692 | 0.290 |
Why?
|
| Case-Control Studies | 10 | 2024 | 3381 | 0.290 |
Why?
|
| RNA Precursors | 4 | 2024 | 147 | 0.290 |
Why?
|
| Multiple Organ Failure | 3 | 2023 | 122 | 0.290 |
Why?
|
| RNA | 3 | 2023 | 883 | 0.290 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1171 | 0.280 |
Why?
|
| Purines | 3 | 2017 | 172 | 0.280 |
Why?
|
| Leukocyte Reduction Procedures | 2 | 2018 | 25 | 0.280 |
Why?
|
| Brain Injuries | 2 | 2022 | 468 | 0.270 |
Why?
|
| Signal Transduction | 14 | 2022 | 4925 | 0.270 |
Why?
|
| Asparagine | 2 | 2018 | 30 | 0.270 |
Why?
|
| Sphingosine | 2 | 2017 | 40 | 0.270 |
Why?
|
| Glioblastoma | 2 | 2022 | 326 | 0.270 |
Why?
|
| Cell Proliferation | 10 | 2021 | 2391 | 0.270 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 663 | 0.270 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2017 | 46 | 0.270 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 195 | 0.270 |
Why?
|
| Proteoglycans | 3 | 2023 | 110 | 0.270 |
Why?
|
| Calcium | 6 | 2023 | 1213 | 0.260 |
Why?
|
| Receptor, Adenosine A2B | 2 | 2017 | 44 | 0.260 |
Why?
|
| Lysophospholipids | 2 | 2017 | 72 | 0.260 |
Why?
|
| Acute-Phase Proteins | 3 | 2024 | 67 | 0.260 |
Why?
|
| Lactation | 2 | 2025 | 170 | 0.260 |
Why?
|
| Cryopreservation | 2 | 2017 | 97 | 0.260 |
Why?
|
| Neutrophil Activation | 2 | 2018 | 79 | 0.260 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2016 | 50 | 0.260 |
Why?
|
| Serpins | 2 | 2024 | 31 | 0.260 |
Why?
|
| Aging | 4 | 2024 | 1776 | 0.260 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2022 | 257 | 0.260 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2012 | 179 | 0.250 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2017 | 592 | 0.250 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 1022 | 0.250 |
Why?
|
| Anemia, Sickle Cell | 3 | 2024 | 254 | 0.250 |
Why?
|
| Blood Component Transfusion | 3 | 2015 | 82 | 0.250 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 2 | 2017 | 11 | 0.250 |
Why?
|
| Blood Transfusion | 6 | 2024 | 296 | 0.250 |
Why?
|
| Drosophila Proteins | 3 | 2017 | 186 | 0.250 |
Why?
|
| Transcriptome | 2 | 2022 | 887 | 0.240 |
Why?
|
| Reactive Oxygen Species | 7 | 2022 | 596 | 0.240 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 1085 | 0.240 |
Why?
|
| Prognosis | 8 | 2022 | 3794 | 0.240 |
Why?
|
| Kynurenine | 3 | 2024 | 114 | 0.240 |
Why?
|
| Fibrinolytic Agents | 3 | 2022 | 263 | 0.240 |
Why?
|
| Cluster Analysis | 3 | 2016 | 482 | 0.240 |
Why?
|
| Obesity | 4 | 2020 | 2882 | 0.240 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2015 | 116 | 0.240 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2019 | 66 | 0.240 |
Why?
|
| Protein Phosphatase 1 | 1 | 2025 | 34 | 0.240 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 497 | 0.240 |
Why?
|
| Biomimetics | 1 | 2025 | 43 | 0.240 |
Why?
|
| Carbon Isotopes | 2 | 2017 | 126 | 0.240 |
Why?
|
| Ventricular Remodeling | 2 | 2024 | 255 | 0.240 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 19 | 0.240 |
Why?
|
| Thrombin | 3 | 2022 | 146 | 0.230 |
Why?
|
| Antivenins | 1 | 2025 | 35 | 0.230 |
Why?
|
| Platelet Transfusion | 2 | 2023 | 59 | 0.230 |
Why?
|
| Cattle | 2 | 2024 | 976 | 0.230 |
Why?
|
| Integrins | 3 | 2023 | 94 | 0.230 |
Why?
|
| Polymorphism, Genetic | 2 | 2025 | 640 | 0.230 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2009 | 137 | 0.230 |
Why?
|
| Survival of Motor Neuron 1 Protein | 2 | 2016 | 9 | 0.230 |
Why?
|
| Altitude | 4 | 2023 | 461 | 0.230 |
Why?
|
| Transglutaminases | 1 | 2025 | 153 | 0.230 |
Why?
|
| Biomimetic Materials | 1 | 2025 | 70 | 0.230 |
Why?
|
| Trypsin | 2 | 2023 | 74 | 0.230 |
Why?
|
| Physical Conditioning, Animal | 2 | 2025 | 229 | 0.230 |
Why?
|
| Printing, Three-Dimensional | 1 | 2025 | 87 | 0.230 |
Why?
|
| Cell Cycle Proteins | 5 | 2015 | 586 | 0.220 |
Why?
|
| Postpartum Hemorrhage | 1 | 2024 | 16 | 0.220 |
Why?
|
| Glycosaminoglycans | 2 | 2022 | 84 | 0.220 |
Why?
|
| Acetaminophen | 2 | 2025 | 246 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 814 | 0.220 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.220 |
Why?
|
| Blood Group Antigens | 1 | 2023 | 16 | 0.220 |
Why?
|
| Bacteria | 2 | 2022 | 820 | 0.220 |
Why?
|
| Carnitine | 1 | 2024 | 76 | 0.220 |
Why?
|
| Brain | 7 | 2021 | 2679 | 0.220 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 22 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 132 | 0.220 |
Why?
|
| Herpesvirus 3, Human | 2 | 2024 | 331 | 0.220 |
Why?
|
| Calcium Signaling | 2 | 2023 | 250 | 0.210 |
Why?
|
| Uric Acid | 1 | 2025 | 161 | 0.210 |
Why?
|
| Repressor Proteins | 2 | 2018 | 406 | 0.210 |
Why?
|
| Milk, Human | 1 | 2025 | 151 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 101 | 0.210 |
Why?
|
| Chromatography | 1 | 2003 | 25 | 0.210 |
Why?
|
| Interferons | 2 | 2022 | 194 | 0.210 |
Why?
|
| Birth Injuries | 1 | 2023 | 10 | 0.210 |
Why?
|
| Hypocalcemia | 1 | 2023 | 28 | 0.210 |
Why?
|
| Betacoronavirus | 3 | 2020 | 249 | 0.210 |
Why?
|
| Fatty Acids | 3 | 2023 | 427 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 380 | 0.210 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2023 | 11 | 0.210 |
Why?
|
| Capillary Permeability | 1 | 2023 | 139 | 0.210 |
Why?
|
| Pteridines | 1 | 2023 | 22 | 0.210 |
Why?
|
| Phenotype | 7 | 2023 | 3076 | 0.210 |
Why?
|
| Introns | 3 | 2019 | 251 | 0.210 |
Why?
|
| Erythrocyte Aging | 3 | 2024 | 13 | 0.210 |
Why?
|
| Isotonic Solutions | 4 | 2016 | 37 | 0.200 |
Why?
|
| Neural Stem Cells | 2 | 2015 | 143 | 0.200 |
Why?
|
| Acclimatization | 4 | 2017 | 164 | 0.200 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2023 | 45 | 0.200 |
Why?
|
| Collagen Type I | 1 | 2023 | 119 | 0.200 |
Why?
|
| Drosophila melanogaster | 3 | 2017 | 215 | 0.200 |
Why?
|
| Phosphorylation | 9 | 2025 | 1713 | 0.200 |
Why?
|
| Dystrophin | 1 | 2023 | 34 | 0.200 |
Why?
|
| Arginase | 1 | 2022 | 32 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 2548 | 0.200 |
Why?
|
| Proteolysis | 4 | 2020 | 166 | 0.200 |
Why?
|
| Herpes Zoster | 2 | 2024 | 317 | 0.200 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2021 | 80 | 0.200 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 149 | 0.200 |
Why?
|
| src-Family Kinases | 1 | 2023 | 96 | 0.200 |
Why?
|
| Mitochondrial Proteins | 3 | 2016 | 248 | 0.200 |
Why?
|
| Ephrin-B2 | 2 | 2021 | 50 | 0.200 |
Why?
|
| Erythroblasts | 1 | 2022 | 15 | 0.200 |
Why?
|
| Hemostasis | 1 | 2023 | 79 | 0.200 |
Why?
|
| Complement C4 | 1 | 2022 | 24 | 0.200 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2022 | 19 | 0.200 |
Why?
|
| Aldehydes | 1 | 2023 | 143 | 0.200 |
Why?
|
| Citrulline | 1 | 2022 | 44 | 0.200 |
Why?
|
| Transcription Factor TFIID | 1 | 2022 | 25 | 0.190 |
Why?
|
| Thrombophilia | 1 | 2022 | 81 | 0.190 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 13 | 0.190 |
Why?
|
| beta-Globins | 1 | 2022 | 8 | 0.190 |
Why?
|
| Athletic Performance | 1 | 2023 | 77 | 0.190 |
Why?
|
| Isoaspartic Acid | 1 | 2021 | 3 | 0.190 |
Why?
|
| Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.190 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 89 | 0.190 |
Why?
|
| Myocytes, Cardiac | 2 | 2024 | 499 | 0.190 |
Why?
|
| Blood | 1 | 2022 | 104 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 196 | 0.190 |
Why?
|
| Pneumonia, Bacterial | 1 | 2022 | 115 | 0.190 |
Why?
|
| Cell Line | 10 | 2021 | 2781 | 0.180 |
Why?
|
| Oxygen | 5 | 2017 | 915 | 0.180 |
Why?
|
| Coinfection | 1 | 2022 | 131 | 0.180 |
Why?
|
| Methods | 2 | 2018 | 64 | 0.180 |
Why?
|
| Cathepsins | 1 | 2021 | 24 | 0.180 |
Why?
|
| Exons | 2 | 2019 | 342 | 0.180 |
Why?
|
| Pregnancy | 10 | 2024 | 6402 | 0.180 |
Why?
|
| Pulmonary Artery | 2 | 2024 | 1096 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2017 | 191 | 0.180 |
Why?
|
| ADAM10 Protein | 1 | 2021 | 30 | 0.180 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2020 | 8 | 0.180 |
Why?
|
| Virulence Factors | 1 | 2022 | 156 | 0.180 |
Why?
|
| Seroconversion | 1 | 2021 | 46 | 0.180 |
Why?
|
| RNA, Messenger | 4 | 2018 | 2708 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2020 | 388 | 0.180 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 35 | 0.180 |
Why?
|
| Mutation | 7 | 2021 | 3717 | 0.180 |
Why?
|
| Transcription, Genetic | 4 | 2025 | 1418 | 0.180 |
Why?
|
| beta-Thalassemia | 1 | 2021 | 37 | 0.180 |
Why?
|
| Tenascin | 2 | 2018 | 14 | 0.180 |
Why?
|
| Glutathione | 3 | 2017 | 348 | 0.180 |
Why?
|
| Benzothiazoles | 2 | 2017 | 32 | 0.170 |
Why?
|
| Endothelium, Vascular | 2 | 2024 | 901 | 0.170 |
Why?
|
| Genome | 1 | 2022 | 278 | 0.170 |
Why?
|
| Oncogene Proteins | 1 | 2020 | 55 | 0.170 |
Why?
|
| Least-Squares Analysis | 2 | 2021 | 78 | 0.170 |
Why?
|
| Thrombomodulin | 1 | 2020 | 10 | 0.170 |
Why?
|
| Hematopoiesis | 2 | 2021 | 183 | 0.170 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 66 | 0.170 |
Why?
|
| Preoperative Period | 2 | 2019 | 115 | 0.170 |
Why?
|
| Lysosomes | 1 | 2021 | 138 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2018 | 544 | 0.170 |
Why?
|
| Trauma Centers | 2 | 2020 | 402 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2020 | 113 | 0.170 |
Why?
|
| RNA, Fungal | 2 | 2017 | 67 | 0.170 |
Why?
|
| Cytochromes | 1 | 2000 | 10 | 0.170 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 231 | 0.170 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 108 | 0.170 |
Why?
|
| Methionine | 2 | 2020 | 158 | 0.170 |
Why?
|
| Databases, Genetic | 1 | 2021 | 232 | 0.170 |
Why?
|
| Electron Transport Complex III | 1 | 2000 | 15 | 0.170 |
Why?
|
| Glycosylation | 4 | 2015 | 150 | 0.170 |
Why?
|
| Phenylurea Compounds | 2 | 2017 | 89 | 0.170 |
Why?
|
| Pancreas | 2 | 2021 | 306 | 0.170 |
Why?
|
| Ubiquinone | 1 | 2000 | 28 | 0.170 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2020 | 29 | 0.170 |
Why?
|
| TCF Transcription Factors | 1 | 2019 | 16 | 0.170 |
Why?
|
| Spermatogenesis | 1 | 2020 | 62 | 0.170 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 610 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 211 | 0.160 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 24 | 0.160 |
Why?
|
| Radiation Injuries | 1 | 2021 | 135 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 64 | 0.160 |
Why?
|
| Acellular Dermis | 1 | 2019 | 12 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2021 | 186 | 0.160 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 221 | 0.160 |
Why?
|
| Semaphorins | 1 | 2020 | 28 | 0.160 |
Why?
|
| Nucleotides | 2 | 2017 | 122 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 1 | 2021 | 112 | 0.160 |
Why?
|
| Parabiosis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Critical Illness | 2 | 2017 | 758 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 340 | 0.160 |
Why?
|
| Chromatin | 3 | 2018 | 479 | 0.160 |
Why?
|
| Heart Failure | 2 | 2023 | 2149 | 0.160 |
Why?
|
| Prescription Drugs | 1 | 2021 | 112 | 0.160 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 310 | 0.160 |
Why?
|
| Methyltransferases | 1 | 2020 | 70 | 0.160 |
Why?
|
| Pilot Projects | 3 | 2022 | 1587 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 310 | 0.160 |
Why?
|
| Cell Survival | 5 | 2022 | 1086 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 5 | 2020 | 485 | 0.160 |
Why?
|
| Semen Analysis | 2 | 2020 | 13 | 0.160 |
Why?
|
| 2,3-Diphosphoglycerate | 4 | 2023 | 32 | 0.160 |
Why?
|
| Torpor | 1 | 2019 | 14 | 0.160 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 474 | 0.160 |
Why?
|
| Blotting, Western | 5 | 2020 | 1205 | 0.160 |
Why?
|
| Receptor, EphB4 | 1 | 2019 | 36 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1565 | 0.150 |
Why?
|
| Thrombospondins | 1 | 2018 | 7 | 0.150 |
Why?
|
| Antifibrinolytic Agents | 2 | 2019 | 47 | 0.150 |
Why?
|
| Chemical Fractionation | 2 | 2016 | 30 | 0.150 |
Why?
|
| Stomach | 1 | 2019 | 109 | 0.150 |
Why?
|
| Fertility | 1 | 2020 | 160 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 239 | 0.150 |
Why?
|
| Infertility, Male | 2 | 2020 | 60 | 0.150 |
Why?
|
| Solubility | 2 | 2017 | 235 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2020 | 107 | 0.150 |
Why?
|
| Aspartic Acid | 1 | 2018 | 81 | 0.150 |
Why?
|
| Coenzymes | 1 | 2018 | 18 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 544 | 0.150 |
Why?
|
| Adipose Tissue | 3 | 2020 | 592 | 0.150 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 23 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 23 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 149 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2022 | 431 | 0.150 |
Why?
|
| Protein Conformation | 4 | 2021 | 859 | 0.150 |
Why?
|
| Arousal | 1 | 2019 | 150 | 0.150 |
Why?
|
| HeLa Cells | 5 | 2025 | 608 | 0.150 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 30 | 0.150 |
Why?
|
| Spermatozoa | 2 | 2020 | 91 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2023 | 111 | 0.150 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 1706 | 0.150 |
Why?
|
| Arteries | 1 | 2020 | 265 | 0.150 |
Why?
|
| Laminin | 2 | 2021 | 69 | 0.150 |
Why?
|
| Rats, Inbred F344 | 2 | 2016 | 257 | 0.150 |
Why?
|
| Protein Binding | 7 | 2025 | 2121 | 0.140 |
Why?
|
| Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hemoglobin, Sickle | 1 | 2017 | 18 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 117 | 0.140 |
Why?
|
| Hemoglobin A | 1 | 2017 | 22 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2018 | 79 | 0.140 |
Why?
|
| Glioma | 1 | 2022 | 354 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 82 | 0.140 |
Why?
|
| Apoptosis | 5 | 2021 | 2503 | 0.140 |
Why?
|
| Hypoxanthine | 1 | 2017 | 11 | 0.140 |
Why?
|
| Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
|
| Glutaminase | 1 | 2017 | 10 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 380 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2025 | 2119 | 0.140 |
Why?
|
| Multienzyme Complexes | 1 | 2017 | 68 | 0.140 |
Why?
|
| Thiadiazoles | 1 | 2017 | 24 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2017 | 31 | 0.140 |
Why?
|
| RNA Splicing Factors | 1 | 2017 | 52 | 0.140 |
Why?
|
| Lung Diseases | 3 | 2018 | 742 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2022 | 902 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
|
| Healthy Volunteers | 4 | 2021 | 200 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2019 | 187 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2020 | 489 | 0.140 |
Why?
|
| Cold Temperature | 2 | 2016 | 155 | 0.140 |
Why?
|
| Fluid Therapy | 2 | 2016 | 134 | 0.140 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.140 |
Why?
|
| Methylation | 5 | 2018 | 230 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2017 | 66 | 0.140 |
Why?
|
| Organ Size | 2 | 2015 | 447 | 0.140 |
Why?
|
| Cystathionine | 1 | 2016 | 24 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2021 | 374 | 0.140 |
Why?
|
| Arachis | 2 | 2009 | 109 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2017 | 218 | 0.140 |
Why?
|
| Binding Sites | 5 | 2021 | 1252 | 0.140 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 60 | 0.140 |
Why?
|
| Basigin | 1 | 2017 | 25 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2024 | 7131 | 0.130 |
Why?
|
| Periodicity | 1 | 2016 | 57 | 0.130 |
Why?
|
| Young Adult | 9 | 2021 | 12426 | 0.130 |
Why?
|
| Chromatography, Affinity | 1 | 2017 | 83 | 0.130 |
Why?
|
| Basement Membrane | 2 | 2016 | 31 | 0.130 |
Why?
|
| Mice, Inbred NOD | 4 | 2023 | 588 | 0.130 |
Why?
|
| Molecular Chaperones | 2 | 2016 | 182 | 0.130 |
Why?
|
| Aorta | 3 | 2024 | 411 | 0.130 |
Why?
|
| Aged | 11 | 2024 | 22099 | 0.130 |
Why?
|
| Leukemia | 1 | 2019 | 230 | 0.130 |
Why?
|
| RNA, Small Nuclear | 2 | 2015 | 35 | 0.130 |
Why?
|
| Detergents | 1 | 2016 | 44 | 0.130 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 66 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 386 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 601 | 0.130 |
Why?
|
| Immunoglobulin E | 2 | 2009 | 329 | 0.130 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 42 | 0.130 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2016 | 40 | 0.130 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 821 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2016 | 8 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2017 | 644 | 0.130 |
Why?
|
| Mycophenolic Acid | 1 | 2017 | 110 | 0.130 |
Why?
|
| Mammals | 3 | 2022 | 271 | 0.130 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 39 | 0.130 |
Why?
|
| RNA Splice Sites | 3 | 2024 | 44 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 442 | 0.130 |
Why?
|
| HEK293 Cells | 4 | 2025 | 697 | 0.130 |
Why?
|
| Folic Acid | 1 | 2017 | 184 | 0.130 |
Why?
|
| Peanut Hypersensitivity | 2 | 2009 | 140 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2009 | 338 | 0.130 |
Why?
|
| Coiled Bodies | 1 | 2016 | 8 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 519 | 0.130 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 60 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 179 | 0.130 |
Why?
|
| Body Temperature | 1 | 2016 | 212 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 81 | 0.130 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 40 | 0.130 |
Why?
|
| Nitrogen | 1 | 2017 | 167 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 79 | 0.130 |
Why?
|
| Phosphatidylethanolamines | 1 | 2016 | 74 | 0.130 |
Why?
|
| Transfusion Medicine | 1 | 2015 | 12 | 0.120 |
Why?
|
| Ubiquitination | 4 | 2018 | 98 | 0.120 |
Why?
|
| Acute Lung Injury | 3 | 2016 | 279 | 0.120 |
Why?
|
| Platelet Function Tests | 1 | 2015 | 25 | 0.120 |
Why?
|
| Receptor, PAR-2 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2000 | 774 | 0.120 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 67 | 0.120 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2016 | 199 | 0.120 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2015 | 26 | 0.120 |
Why?
|
| Integrin beta3 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Cysteine | 1 | 2016 | 195 | 0.120 |
Why?
|
| Anoikis | 1 | 2015 | 31 | 0.120 |
Why?
|
| Tryptophan Oxygenase | 1 | 2015 | 35 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 3083 | 0.120 |
Why?
|
| Bison | 1 | 2015 | 6 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 790 | 0.120 |
Why?
|
| Acidosis | 1 | 2016 | 89 | 0.120 |
Why?
|
| Plasminogen | 1 | 2015 | 31 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 240 | 0.120 |
Why?
|
| Macrophages | 2 | 2021 | 1480 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 51 | 0.120 |
Why?
|
| Blood Circulation | 1 | 2015 | 41 | 0.120 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 146 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 370 | 0.120 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.120 |
Why?
|
| Breast | 3 | 2021 | 153 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2016 | 672 | 0.120 |
Why?
|
| Allergens | 2 | 2009 | 385 | 0.120 |
Why?
|
| Blood Volume | 1 | 2015 | 60 | 0.120 |
Why?
|
| RNA Helicases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2020 | 683 | 0.120 |
Why?
|
| Microcirculation | 1 | 2015 | 145 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 29 | 0.120 |
Why?
|
| Europe | 1 | 2015 | 364 | 0.120 |
Why?
|
| Serine Proteases | 1 | 2014 | 20 | 0.120 |
Why?
|
| Pulmonary Alveoli | 2 | 2008 | 400 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 146 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 169 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1071 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 1056 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 153 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 137 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2022 | 178 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 570 | 0.110 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 24 | 0.110 |
Why?
|
| Aurora Kinase A | 1 | 2014 | 55 | 0.110 |
Why?
|
| Skull | 1 | 2015 | 129 | 0.110 |
Why?
|
| Seasons | 1 | 2016 | 502 | 0.110 |
Why?
|
| Complex Mixtures | 1 | 2014 | 11 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 940 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2015 | 121 | 0.110 |
Why?
|
| Snake Venoms | 2 | 2024 | 21 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2015 | 206 | 0.110 |
Why?
|
| Adenosine Triphosphate | 3 | 2024 | 480 | 0.110 |
Why?
|
| Rejuvenation | 1 | 2013 | 18 | 0.110 |
Why?
|
| GPI-Linked Proteins | 3 | 2020 | 68 | 0.110 |
Why?
|
| Fetal Development | 1 | 2016 | 288 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 457 | 0.110 |
Why?
|
| Metalloproteases | 2 | 2024 | 44 | 0.110 |
Why?
|
| Spindle Apparatus | 1 | 2014 | 94 | 0.110 |
Why?
|
| Microcephaly | 1 | 2014 | 87 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 495 | 0.110 |
Why?
|
| Mexico | 2 | 2025 | 190 | 0.110 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 30 | 0.110 |
Why?
|
| Serine | 2 | 2023 | 138 | 0.110 |
Why?
|
| Cell Culture Techniques | 3 | 2013 | 345 | 0.110 |
Why?
|
| Estradiol | 2 | 2022 | 494 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2020 | 452 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2017 | 534 | 0.100 |
Why?
|
| Cryoelectron Microscopy | 3 | 2019 | 178 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 53 | 0.100 |
Why?
|
| Mitosis | 1 | 2014 | 180 | 0.100 |
Why?
|
| Sex Factors | 3 | 2025 | 1968 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 192 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2017 | 499 | 0.100 |
Why?
|
| Cumulus Cells | 1 | 2012 | 6 | 0.100 |
Why?
|
| Interleukin-1 | 1 | 2017 | 958 | 0.100 |
Why?
|
| MicroRNAs | 4 | 2024 | 678 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 1181 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 197 | 0.100 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 42 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 898 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 42 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 511 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 315 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2013 | 326 | 0.100 |
Why?
|
| Growth Cones | 1 | 2012 | 7 | 0.100 |
Why?
|
| Stem Cells | 3 | 2022 | 577 | 0.100 |
Why?
|
| Maternal Age | 1 | 2012 | 124 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 752 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2016 | 387 | 0.100 |
Why?
|
| Catalytic Domain | 4 | 2018 | 218 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 390 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 4896 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 853 | 0.100 |
Why?
|
| 2S Albumins, Plant | 2 | 2009 | 29 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 590 | 0.100 |
Why?
|
| Synaptotagmin I | 1 | 2011 | 13 | 0.090 |
Why?
|
| Antigens, Plant | 2 | 2009 | 48 | 0.090 |
Why?
|
| Protein Folding | 4 | 2018 | 266 | 0.090 |
Why?
|
| Exoribonucleases | 1 | 2012 | 43 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 759 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 1952 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 640 | 0.090 |
Why?
|
| beta 2-Microglobulin | 1 | 2011 | 49 | 0.090 |
Why?
|
| Leukocytes | 1 | 2013 | 304 | 0.090 |
Why?
|
| Cell Movement | 4 | 2021 | 945 | 0.090 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 15 | 0.090 |
Why?
|
| Datasets as Topic | 2 | 2022 | 110 | 0.090 |
Why?
|
| Lipocalin 1 | 1 | 2011 | 2 | 0.090 |
Why?
|
| Transfusion Reaction | 1 | 2011 | 43 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2019 | 831 | 0.090 |
Why?
|
| RNA Stability | 1 | 2012 | 102 | 0.090 |
Why?
|
| Blastocyst | 1 | 2011 | 47 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 587 | 0.090 |
Why?
|
| Lactates | 2 | 2023 | 85 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 2061 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 162 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2011 | 92 | 0.090 |
Why?
|
| DNA | 3 | 2022 | 1400 | 0.090 |
Why?
|
| Lipid Peroxidation | 2 | 2025 | 151 | 0.090 |
Why?
|
| Axons | 1 | 2012 | 191 | 0.090 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2011 | 107 | 0.080 |
Why?
|
| Phylogeny | 2 | 2025 | 852 | 0.080 |
Why?
|
| Isoantigens | 1 | 2009 | 13 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 857 | 0.080 |
Why?
|
| Water | 2 | 2022 | 448 | 0.080 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 13 | 0.080 |
Why?
|
| Models, Biological | 4 | 2021 | 1721 | 0.080 |
Why?
|
| Ischemia | 2 | 2023 | 406 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 1333 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 65 | 0.080 |
Why?
|
| Exercise | 2 | 2023 | 1924 | 0.080 |
Why?
|
| Virulence | 2 | 2022 | 255 | 0.080 |
Why?
|
| Fibrin Clot Lysis Time | 2 | 2019 | 9 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 190 | 0.080 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 21 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 42 | 0.080 |
Why?
|
| Protein Interaction Mapping | 2 | 2012 | 108 | 0.080 |
Why?
|
| Endopeptidases | 2 | 2006 | 87 | 0.080 |
Why?
|
| Bronchoscopes | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1902 | 0.080 |
Why?
|
| Complement Activation | 2 | 2022 | 376 | 0.080 |
Why?
|
| S100 Proteins | 1 | 2008 | 36 | 0.070 |
Why?
|
| Tryptophan | 2 | 2020 | 179 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2009 | 200 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2009 | 158 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2020 | 840 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 548 | 0.070 |
Why?
|
| Adolescent | 6 | 2021 | 20391 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 339 | 0.070 |
Why?
|
| Sulfur | 2 | 2019 | 51 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 4 | 2009 | 110 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2016 | 1165 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2018 | 1651 | 0.070 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.070 |
Why?
|
| NADP | 2 | 2018 | 46 | 0.070 |
Why?
|
| Computational Biology | 3 | 2012 | 599 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 186 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 307 | 0.070 |
Why?
|
| Heart Ventricles | 2 | 2023 | 781 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2470 | 0.070 |
Why?
|
| Cross-Linking Reagents | 2 | 2025 | 205 | 0.070 |
Why?
|
| Sheep | 2 | 2021 | 837 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2008 | 212 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 104 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 3 | 2019 | 122 | 0.070 |
Why?
|
| Interleukin-13 | 1 | 2008 | 147 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 171 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2011 | 743 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 375 | 0.070 |
Why?
|
| Biocompatible Materials | 2 | 2022 | 395 | 0.070 |
Why?
|
| Isoenzymes | 2 | 2024 | 302 | 0.070 |
Why?
|
| Plant Proteins | 1 | 2007 | 89 | 0.070 |
Why?
|
| 5'-Nucleotidase | 2 | 2017 | 41 | 0.070 |
Why?
|
| Ligands | 2 | 2019 | 622 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2008 | 242 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2018 | 131 | 0.070 |
Why?
|
| Neurons | 1 | 2015 | 1511 | 0.070 |
Why?
|
| Cell Respiration | 2 | 2017 | 98 | 0.070 |
Why?
|
| Protein Transport | 3 | 2016 | 428 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2023 | 5420 | 0.060 |
Why?
|
| Kupffer Cells | 1 | 2006 | 49 | 0.060 |
Why?
|
| Homeostasis | 2 | 2021 | 611 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2008 | 307 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 636 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 2 | 2017 | 187 | 0.060 |
Why?
|
| Insulin | 1 | 2016 | 2326 | 0.060 |
Why?
|
| Larva | 2 | 2017 | 214 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2018 | 539 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 2 | 2020 | 177 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2004 | 482 | 0.060 |
Why?
|
| Lethal Dose 50 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Dithiothreitol | 1 | 2005 | 17 | 0.060 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2025 | 12 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2025 | 73 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 44 | 0.060 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Fibronectins | 2 | 2020 | 123 | 0.060 |
Why?
|
| Chromosome Segregation | 2 | 2015 | 40 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 155 | 0.060 |
Why?
|
| Cystine | 2 | 2020 | 17 | 0.060 |
Why?
|
| Phosphofructokinases | 1 | 2024 | 7 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 331 | 0.060 |
Why?
|
| Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 197 | 0.060 |
Why?
|
| Hexokinase | 1 | 2024 | 18 | 0.060 |
Why?
|
| Fanconi Syndrome | 1 | 2004 | 2 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 50 | 0.060 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 319 | 0.060 |
Why?
|
| RNA Interference | 2 | 2017 | 448 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 2 | 2016 | 116 | 0.060 |
Why?
|
| Varicella Zoster Virus Infection | 1 | 2024 | 25 | 0.060 |
Why?
|
| ABO Blood-Group System | 1 | 2024 | 39 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 891 | 0.060 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
|
| Saccharomycetales | 1 | 2024 | 26 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 84 | 0.060 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2024 | 23 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 1877 | 0.060 |
Why?
|
| Hematocrit | 1 | 2024 | 93 | 0.060 |
Why?
|
| Ion Channels | 1 | 2004 | 133 | 0.060 |
Why?
|
| Urine | 1 | 2004 | 60 | 0.060 |
Why?
|
| Virus Activation | 1 | 2024 | 88 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 88 | 0.050 |
Why?
|
| Linear Models | 2 | 2017 | 819 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2025 | 110 | 0.050 |
Why?
|
| TRPV Cation Channels | 1 | 2023 | 36 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 2 | 2022 | 213 | 0.050 |
Why?
|
| Species Specificity | 1 | 2025 | 575 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2021 | 1089 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2023 | 23 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 2024 | 103 | 0.050 |
Why?
|
| Succinates | 1 | 2023 | 23 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2019 | 1156 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2004 | 125 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 25 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2023 | 18 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 20 | 0.050 |
Why?
|
| Perfusion | 1 | 2004 | 197 | 0.050 |
Why?
|
| Genome, Human | 2 | 2022 | 393 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2023 | 13 | 0.050 |
Why?
|
| Factor V | 1 | 2023 | 18 | 0.050 |
Why?
|
| Phospholipases A2 | 1 | 2023 | 79 | 0.050 |
Why?
|
| Reperfusion | 1 | 2023 | 38 | 0.050 |
Why?
|
| Dasatinib | 1 | 2023 | 54 | 0.050 |
Why?
|
| Cytotoxins | 1 | 2022 | 16 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 69 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2023 | 41 | 0.050 |
Why?
|
| Heparitin Sulfate | 1 | 2022 | 43 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2018 | 594 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 60 | 0.050 |
Why?
|
| Iron | 1 | 2025 | 288 | 0.050 |
Why?
|
| Thymidine | 1 | 2022 | 59 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2023 | 143 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2025 | 355 | 0.050 |
Why?
|
| P-Selectin | 1 | 2022 | 27 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 157 | 0.050 |
Why?
|
| Random Allocation | 1 | 2023 | 346 | 0.050 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2023 | 145 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2022 | 36 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2022 | 28 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2023 | 172 | 0.050 |
Why?
|
| Erythropoiesis | 1 | 2022 | 51 | 0.050 |
Why?
|
| alpha-Globins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Glutamic Acid | 2 | 2017 | 237 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 70 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2022 | 115 | 0.050 |
Why?
|
| Bicycling | 1 | 2023 | 116 | 0.050 |
Why?
|
| Exosomes | 1 | 2023 | 96 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 62 | 0.050 |
Why?
|
| Platelet Aggregation | 1 | 2022 | 95 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2024 | 328 | 0.050 |
Why?
|
| Platelet Activation | 1 | 2022 | 91 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 232 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2023 | 183 | 0.050 |
Why?
|
| United States | 2 | 2015 | 13900 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 226 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 131 | 0.050 |
Why?
|
| Ranitidine | 1 | 2021 | 14 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 214 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2021 | 33 | 0.050 |
Why?
|
| Hypoalbuminemia | 1 | 2021 | 30 | 0.050 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2020 | 8 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 376 | 0.040 |
Why?
|
| Access to Information | 1 | 2021 | 47 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2073 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2021 | 101 | 0.040 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2022 | 106 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 56 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 226 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2016 | 840 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2024 | 527 | 0.040 |
Why?
|
| Bacteriophage lambda | 1 | 2021 | 88 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 276 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 156 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2022 | 441 | 0.040 |
Why?
|
| Gene Expression | 2 | 2019 | 1472 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cell Count | 2 | 2013 | 314 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 1304 | 0.040 |
Why?
|
| Disease Progression | 2 | 2020 | 2635 | 0.040 |
Why?
|
| Polyamines | 1 | 2020 | 39 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2022 | 187 | 0.040 |
Why?
|
| Data Mining | 1 | 2021 | 110 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 59 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 58 | 0.040 |
Why?
|
| Sperm Count | 1 | 2020 | 17 | 0.040 |
Why?
|
| Heterozygote | 1 | 2021 | 272 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 34 | 0.040 |
Why?
|
| Cytochrome b Group | 1 | 2000 | 19 | 0.040 |
Why?
|
| Rabbits | 2 | 2014 | 778 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1356 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2020 | 30 | 0.040 |
Why?
|
| CD146 Antigen | 1 | 2020 | 41 | 0.040 |
Why?
|
| Genotype | 2 | 2016 | 1839 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 201 | 0.040 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2021 | 164 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 116 | 0.040 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2019 | 43 | 0.040 |
Why?
|
| Electron Transport | 1 | 2000 | 112 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 206 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 109 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 2009 | 127 | 0.040 |
Why?
|
| Photochemistry | 1 | 2000 | 132 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 362 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2014 | 592 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 195 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2018 | 16 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 326 | 0.040 |
Why?
|
| Pepsin A | 1 | 2018 | 19 | 0.040 |
Why?
|
| Surface Tension | 1 | 2018 | 7 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2019 | 91 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 301 | 0.040 |
Why?
|
| Blood Buffy Coat | 1 | 2018 | 4 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 104 | 0.040 |
Why?
|
| Drug Design | 1 | 2019 | 156 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 636 | 0.040 |
Why?
|
| Sulfates | 1 | 2018 | 50 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2011 | 332 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2021 | 355 | 0.040 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2020 | 2097 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 69 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 77 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 232 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 491 | 0.040 |
Why?
|
| Fluorescence | 1 | 2018 | 160 | 0.040 |
Why?
|
| Filtration | 1 | 2018 | 67 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 180 | 0.040 |
Why?
|
| Acute Disease | 2 | 2013 | 980 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2019 | 188 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2000 | 178 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2024 | 14519 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2018 | 69 | 0.040 |
Why?
|
| Deamination | 1 | 2017 | 5 | 0.040 |
Why?
|
| Nitrogen Isotopes | 1 | 2017 | 58 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 467 | 0.040 |
Why?
|
| Crush Injuries | 1 | 2017 | 9 | 0.040 |
Why?
|
| Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2023 | 738 | 0.040 |
Why?
|
| Base Pairing | 1 | 2017 | 61 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2019 | 217 | 0.040 |
Why?
|
| Freezing | 1 | 2017 | 86 | 0.040 |
Why?
|
| Base Sequence | 2 | 2013 | 2142 | 0.040 |
Why?
|
| Metabolism | 1 | 2017 | 38 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2017 | 68 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 857 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2017 | 81 | 0.030 |
Why?
|
| Rats, Zucker | 2 | 2008 | 30 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 613 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2017 | 38 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 177 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2018 | 77 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 466 | 0.030 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 325 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 426 | 0.030 |
Why?
|
| Primates | 1 | 2018 | 120 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2017 | 82 | 0.030 |
Why?
|
| Body Fluids | 1 | 2017 | 63 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1097 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 2017 | 73 | 0.030 |
Why?
|
| Mast Cells | 2 | 2009 | 142 | 0.030 |
Why?
|
| Weaning | 1 | 2016 | 48 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 181 | 0.030 |
Why?
|
| Military Personnel | 2 | 2014 | 515 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2017 | 82 | 0.030 |
Why?
|
| Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Macaca | 1 | 2016 | 54 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2016 | 62 | 0.030 |
Why?
|
| Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
|
| Hydrazines | 1 | 2016 | 34 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2020 | 607 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 81 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 52 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 2016 | 53 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 113 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 71 | 0.030 |
Why?
|
| Adventitia | 1 | 2016 | 43 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2016 | 38 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 133 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1547 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 95 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2017 | 218 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 1876 | 0.030 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2016 | 22 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1245 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 298 | 0.030 |
Why?
|
| Blood Viscosity | 1 | 2015 | 16 | 0.030 |
Why?
|
| Machine Learning | 1 | 2021 | 443 | 0.030 |
Why?
|
| Chromatids | 1 | 2015 | 8 | 0.030 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 193 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 286 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1385 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 287 | 0.030 |
Why?
|
| Biochemistry | 1 | 2015 | 38 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2006 | 27 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 80 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 173 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 616 | 0.030 |
Why?
|
| Presenilin-1 | 2 | 2006 | 31 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 142 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2015 | 77 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 347 | 0.030 |
Why?
|
| Chromosomes | 1 | 2015 | 101 | 0.030 |
Why?
|
| Electroporation | 1 | 2015 | 37 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 187 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2015 | 50 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 338 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 135 | 0.030 |
Why?
|
| Reproduction | 1 | 2016 | 197 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 74 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 196 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 102 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 259 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 764 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 356 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 266 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 546 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1698 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2014 | 27 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 351 | 0.030 |
Why?
|
| Seminal Plasma Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 811 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 911 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2018 | 328 | 0.030 |
Why?
|
| Running | 1 | 2017 | 223 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2014 | 18 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 348 | 0.030 |
Why?
|
| Cations | 1 | 2014 | 80 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 2014 | 28 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 2005 | 118 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2016 | 349 | 0.030 |
Why?
|
| Fetal Stem Cells | 1 | 2013 | 8 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2014 | 76 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 993 | 0.030 |
Why?
|
| DNA Repair | 1 | 2015 | 207 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 613 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 3240 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1040 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2014 | 114 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 118 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1274 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 875 | 0.030 |
Why?
|
| Enzymes | 1 | 2013 | 67 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 401 | 0.030 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2013 | 22 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2013 | 90 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2012 | 3 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 429 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 867 | 0.030 |
Why?
|
| Oocyte Donation | 1 | 2012 | 4 | 0.030 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2012 | 14 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 613 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 770 | 0.030 |
Why?
|
| Athletes | 1 | 2016 | 409 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2015 | 273 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 1106 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 162 | 0.020 |
Why?
|
| Fetus | 1 | 2016 | 773 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 170 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2012 | 64 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 188 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 663 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1502 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 732 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 653 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2020 | 2273 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2014 | 215 | 0.020 |
Why?
|
| Insecta | 1 | 2011 | 65 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 636 | 0.020 |
Why?
|
| Hospitalization | 1 | 2021 | 2070 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 161 | 0.020 |
Why?
|
| Embryo Culture Techniques | 1 | 2011 | 11 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 341 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 524 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 10226 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 110 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 400 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2009 | 7 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 559 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 65 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2009 | 148 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 99 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 30 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 184 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2009 | 24 | 0.020 |
Why?
|
| Sirtuins | 1 | 2009 | 39 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 332 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 282 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 387 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 305 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 2017 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 246 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2008 | 57 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2742 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 522 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 359 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 958 | 0.020 |
Why?
|
| Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
|
| Basophil Degranulation Test | 1 | 2007 | 6 | 0.020 |
Why?
|
| Colorado | 1 | 2017 | 4420 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 212 | 0.020 |
Why?
|
| Estrogens | 1 | 2010 | 347 | 0.020 |
Why?
|
| Basophils | 1 | 2007 | 73 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1367 | 0.020 |
Why?
|
| Tidal Volume | 1 | 2007 | 84 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 9763 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 874 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2007 | 77 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 793 | 0.020 |
Why?
|
| DNA Damage | 1 | 2009 | 384 | 0.020 |
Why?
|
| Presenilin-2 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2006 | 7 | 0.020 |
Why?
|
| Calgranulin B | 1 | 2006 | 7 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 136 | 0.020 |
Why?
|
| Peroxidases | 1 | 2006 | 33 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2006 | 24 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 335 | 0.020 |
Why?
|
| Child | 2 | 2021 | 20882 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 101 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 69 | 0.020 |
Why?
|
| Autoanalysis | 1 | 2005 | 8 | 0.020 |
Why?
|
| Peroxidase | 1 | 2006 | 174 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 368 | 0.020 |
Why?
|
| Point Mutation | 1 | 2006 | 225 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 361 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 129 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2007 | 199 | 0.010 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 6 | 0.010 |
Why?
|
| Calibration | 1 | 2005 | 140 | 0.010 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 22 | 0.010 |
Why?
|
| Complement C3 | 1 | 2006 | 203 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 436 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 210 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 186 | 0.010 |
Why?
|
| Deuterium | 1 | 2005 | 87 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2004 | 19 | 0.010 |
Why?
|
| PrPC Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2004 | 11 | 0.010 |
Why?
|
| Static Electricity | 1 | 2004 | 116 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2004 | 29 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2004 | 52 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 218 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 426 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 376 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3628 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2004 | 60 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 342 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 235 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 2012 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1720 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 2440 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2004 | 308 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 10518 | 0.010 |
Why?
|